article_metadata: Wanrui Lv Ke Cheng Xiaofen Li Lusi Feng Hancong Li Jia Li Chen Chang Dan Cao
article_metadata: 10.3389/fonc.2021.759652
article_metadata: Front Oncol
article_metadata: 2022 Jan 13;11:759652.
article_metadata: ebv-associated gastric cancer camrelizumab favorable response immunotherapy manageable toxicity programmed cell death ligand-1 (pd-l1) positive
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/35096571/
article_metadata: Case Reports
article_metadata: PMC8791849
article_metadata: 35096571
article_metadata: Case Report: Favorable Response and Manageable Toxicity to the Combination of Camrelizumab, Oxaliplatin, and Oral S-1 in a Patient With Advanced Epstein-Barr Virus-Associated Gastric Cancer
article_metadata: 2022